Scientists say they’ve zeroed in on a cause of Alzheimer’s
By
Alicia Lasek
Dec 03, 2021
Researchers from the University of California, Riverside say they have uncovered a reason why some people with plaques and tangles in their brains do not develop Alzheimer’s disease.
Intervention can cut risk for mobility disability in seniors
May 13, 2022
Reduced incidence of mobility disability is seen in older adults with physical frailty and sarcopenia receiving who receive a multicomponent intervention.
CDC: Prevalence of severe arthritis pain has risen across U.S.
By
Alicia Lasek (f3)
May 04, 2022
Certain states are especially ripe for arthritis-related health interventions, a study of state data reveals.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Male urinary symptoms may indicate mortality risk over time
May 03, 2022
Moderate-to-severe male lower urinary tract symptoms are associated with an increased risk of death during long-term follow-up, investigators say.
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
CDC: Lasting COVID-19 symptoms tied to age, sex, race factors
By
Alicia Lasek
Sep 21, 2021
Investigators examined recovered COVID-19 patients in Long Beach California. Fully one third of participants reported having at least one symptom of post-acute sequelae, commonly called “long COVID-19,”...